Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials
Sakai, Soichi, Kaku, Kohei, Seino, Yutaka, Inagaki, Nobuya, Haneda, Masakazu, Sasaki, Takashi, Fukatsu, Atsushi, Kakiuchi, Haruka, Samukawa, YoshishigeLanguage:
english
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2016.01.017
Date:
March, 2016
File:
PDF, 1.46 MB
english, 2016